NewsJul | 1 | 2020
Lee Zou, PhD and Raul Mostoslavsky, MD, PhD Named Scientific co-Directors of the Mass General Cancer Center and Center for Cancer Research
After nine years as the Scientific Director of the Mass General Cancer Center and Center for Cancer Research, Dr. Nick Dyson is stepping down from his role to better focus on his research on the role of the retinoblastoma tumor suppressor gene (RB) in the regulation of cell proliferation and its frequent loss in small cell lung carcinoma. Dr. Dyson has helped shape our direction in cancer research, and he has mentored countless faculty, trainees, and staff with compassion and kindness.
Succeeding Nick will be Lee Zou, PhD and Raul Mostoslavsky, MD, PhD, who will serve as Scientific co-Directors. Lee Zou, the Poitras Family Chair in Cancer Research at Mass General and Professor of Pathology at Harvard Medical School, is a renowned authority on DNA damage repair, the role of ATR signaling in cancer cell replication stress, and pathways targeted by inhibitors of DNA homologous recombination. Lee has served as Associate Scientific Director for the past nine years. Joining him as co-Director will be Raul Mostoslavsky, the Laurel Schwartz Professor of Oncology (Medicine) at Harvard Medical School and Mass General, an internationally recognized investigator in the field of metabolism and pancreatic cancer, specifically the interaction between cancer epigenetics, chromatin dynamics and cellular metabolism. Both of these highly accomplished researchers are ready to ensure that Mass General Cancer Center continues on its outstanding trajectory of discovery and innovation in cancer research.